Giallongo C. et al. identified that MDSCs (CD11b+CD33+CD14−HLA-DR−) were elevated at diagnosis and decreased to normal levels after imatinib therapy in CML patients [57]. The gene discussed is ITGAM; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.